HaystackAnalytics key facts
as of Oct 2026- Developer of genomic diagnostic tools designed for the rapid identification of infectious diseases.
- HaystackAnalytics is valued at approximately $70.0M as of Oct 2026 (last reported valuation).
- It has raised $15.0M.
- Notable investors include Society for Innovation and Entrepreneurship, BIRAC, 1Crowd, Aeroflex Enterprises, Alkem Laboratories — 13 tracked in total.
- Status: Privately Held (backing).
HaystackAnalytics's last reported valuation, Mar 2026. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch HaystackAnalytics: the Monday email on marks, rounds and moves
HaystackAnalytics funding rounds
No funding rounds for HaystackAnalytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs HaystackAnalytics
13+HaystackAnalytics valuation
HaystackAnalytics's last reported valuation was $70 million in Mar 2026. No priced round, secondary trade or fund mark has surfaced since.
HaystackAnalytics investors
13 investors are on record for HaystackAnalytics, including Society for Innovation and Entrepreneurship, BIRAC, 1Crowd and Aeroflex Enterprises.
About HaystackAnalytics
Developer of genomic diagnostic tools designed for the rapid identification of infectious diseases. The company's platform utilizes next-generation sequencing and bioinformatics to detect a wide range of pathogens and identify antimicrobial resistance genes, rapidly delivering results, enabling healthcare providers in clinical settings to make faster, evidence-based treatment decisions and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Mumbai, India
- Founded
- 2018
- Employees
- 177
- Website
- haystackanalytics.in/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.